Leritone Junior
Leritone Junior, licence 80022650: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- IRB Yves Ponroy Canada Inc.
- NPN or DIN-HM
- 80022650
- Status
- Active licence
- Licence date
- 3 December 2010
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide pantothénique Source : Pantothénate de calcium | 7.5 mg | Not calculated |
| Phospholipides Source : Blanc d'oeuf | 42.5 mg | Not calculated |
| Vitamine B6 Source : Pyridoxine HCl | 1.5 mg | Not calculated |
| Riboflavine Source : Microorganism fermentation | 3.75 mg | Not calculated |
| Thiamine Source : Chlorhydrate de thiamine | 2.25 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Caramel, Acide citrique, acacia, citrate de sodium, Silice Colloïdale, Cellulose, microcristalline, Maltodextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Enfants | minimum: 4.0 Année(s) ; maximum: 12.0 Année(s) | 2.0 Capsule | 1.0 Jour(s) |
| Adolescentes | minimum: 13.0 Année(s) ; maximum: 18.0 Année(s) | 2.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
Recommandé chez l'enfant et l'adolescent pour maintenir une bonne santé.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80022650
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.